Yamada Naoya, Sanada Yukihiro, Katano Takumi, Tashiro Masahisa, Hirata Yuta, Okada Noriki, Ihara Yoshiyuki, Miki Atsushi, Sasanuma Hideki, Urahashi Taizen, Sakuma Yasunaru, Mizuta Koichi
Naoya Yamada, Yukihiro Sanada, Takumi Katano, Masahisa Tashiro, Yuta Hirata, Noriki Okada, Yoshiyuki Ihara, Taizen Urahashi, Koichi Mizuta, Department of Transplant Surgery, Jichi Medical University, Shimotsuke-shi, Tochigi 329-0498, Japan.
World J Gastroenterol. 2016 Nov 28;22(44):9865-9870. doi: 10.3748/wjg.v22.i44.9865.
This is the first report of living donor liver transplantation (LDLT) for congenital hepatic fibrosis (CHF) using a mother's graft with von Meyenburg complex. A 6-year-old girl with CHF, who suffered from recurrent gastrointestinal bleeding, was referred to our hospital for liver transplantation. Her 38-year-old mother was investigated as a living donor and multiple biliary hamartoma were seen on her computed tomography and magnetic resonance imaging scan. The mother's liver function tests were normal and she did not have any organ abnormality, including polycystic kidney disease. LDLT using the left lateral segment (LLS) graft from the donor was performed. The donor LLS graft weighed 250 g; the graft recipient weight ratio was 1.19%. The operation and post-operative course of the donor were uneventful and she was discharged on post-operative day (POD) 8. The graft liver function was good, and the recipient was discharged on POD 31. LDLT using a graft with von Meyenburg complex is safe and useful. Long-term follow-up is needed with respect to graft liver function and screening malignant tumors.
这是首例使用患有胆管错构瘤的母亲的移植物进行活体肝移植(LDLT)治疗先天性肝纤维化(CHF)的报告。一名患有CHF且反复出现胃肠道出血的6岁女孩被转诊至我院进行肝移植。对其38岁的母亲进行了活体供体评估,在她的计算机断层扫描和磁共振成像扫描中发现了多发胆管错构瘤。母亲的肝功能检查正常,且没有任何器官异常,包括多囊肾病。采用了供体的左外侧叶(LLS)移植物进行LDLT。供体LLS移植物重250 g;移植物与受者体重比为1.19%。供体的手术及术后过程顺利,术后第8天出院。移植肝功能良好,受者于术后第31天出院。使用患有胆管错构瘤的移植物进行LDLT是安全且有效的。需要对移植肝功能和筛查恶性肿瘤进行长期随访。